Evidence map›Paper›PMID 19013296›Full record

ArticleMetabolism: clinical and experimental2008

Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.

Mary B Engler, Clive R Pullinger, Mary J Malloy, Yanina Natanzon, Medha V Kulkarni, James Song, Celeste Eng, Jaarko Huuskonen, Christopher Rivera, Annie Poon and 5 more

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2013
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Mary B EnglerDepartment of Physiological Nursing, University of California San Francisco, San Francisco, CA 94143, USA.
Clive R Pullinger
Mary J Malloy
Yanina Natanzon
Medha V Kulkarni
James Song
Celeste Eng
Jaarko Huuskonen
Christopher Rivera
Annie Poon
Matt Bensley
Amy Sehnert
Christian Zellner
John Kane
Bradley E Aouizerat
University of California, San Francisco · US

Funding

MOLECULAR AND CELLULAR BASIS OF CARDIOVASCULAR DISEASET32HL007731 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian L Black · 1992 to 2026
$12.4M
Phospholipid Transfer Protein Mutations In DyslipidemiasK01NR007888 · NINR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ENGLER, MARY B · 2002 to 2004
$277k
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USER01AA011205 · NIAAA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MALLOY, MARY J · 1996 to 2000
$223k
DETERMINENTS OF CORONARY DISEASER01HL050779 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MALLOY, MARY J · 1994 to 1997
–
SPECIATION OF HDL AND LDLR01HL050782 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KANE, JOHN P · 1994 to 1997
–
NHLBI NIH HHS HL50779NHLBI NIH HHS HL50782NHLBI NIH HHS T32 HL007731NHLBI NIH HHS T32 HL07731NIAAA NIH HHS AA11205NINR NIH HHS K01 NR007888NINR NIH HHS K01 NR07888
6 · The paper itself

Abstract

We previously demonstrated the role of a phospholipid transfer protein (PLTP) gene variation (rs2294213) in determining levels of high-density lipoprotein cholesterol (HDL-C) in hypoalphalipoproteinemia (HypoA). We have now explored the role of PLTP in hyperalphalipoproteinemia (HyperA). The human PLTP gene was screened for sequence anomalies by DNA melting in 107 subjects with HyperA. The association with plasma lipoprotein levels was evaluated. We detected 7 sequence variations: 1 previously reported variation (rs2294213) and 5 novel mutations including 1 missense mutation (L106F). The PLTP activity was unchanged in the p.L106F mutation. The frequency of the rs2294213 minor allele was markedly increased in the HyperA group (7.0%) in comparison with a control group (4.3%) and the hypoalphalipoproteinemia group (2.2%). Moreover, rs2294213 was strongly associated with HDL-C levels. Linear regression models predict that possession of the rs2294213 minor allele increases HDL-C independent of triglycerides. These findings extend the association of rs2294213 with HDL-C levels into the extremes of the HDL distribution.

Indexed as

AdultAgedAnimalsCase-Control StudiesChlorocebus aethiopsCOS CellsFemaleGenetic LinkageGenetic VariationHumansHyperlipoproteinemiasLipoproteinsLipoproteins, HDLMaleMiddle AgedPhospholipid Transfer ProteinsLipoproteinsLipoproteins, HDLPhospholipid Transfer Proteins

Identifiers

PMID19013296
PMCPMC2615231
OpenAlexW2033077904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.